基于母乳蛋白组成优化婴儿配方奶粉蛋白质组分的意义、进展与挑战

doi:10.12372/jcp.2025.25e0684

Abstract

Abstract:

Human milk is the optimal food for infants. Proteins in human milk provide essential amino acid for growth, and multiple bioactivities for immunity and neurodevelopment. As a breastfeeding substitute, the ultimate goal of infant formula modification is a feeding outcome similar to breast feeding. The strategies to optimize proteins in infant formula including: lower protein content, addition of validated human milk bioactive proteins, adjustment of protein structure based on human milk. Although efforts have been made, there is still a huge gap between human milk and infant formula which need further research.

Key words: human milk, protein, infant formula

CLC Number:

JIANG Zhuoqin. The significance, progress and challenges of optimizing the protein composition of infant formula based on human breast milk[J].Journal of Clinical Pediatrics, 2025, 43(8): 569-574.

References 34

[1]	中华人民共和国中央人民政府. 母乳喂养促进行动计划(2021-2025年)文件解读[EB/OL]. [2025-06-09]. https://www.gov.cn/zhengce/2021-11/25/content_5653303.htm.
[2]	中国发展研究基金会. 中国母乳喂养影响因素调查报告(会议版)[EB/OL]. 2019 [2025-06-09]. https://www.cdrf.org.cn/jjh/pdf/mu.pdf.
[3]	Li Q, Tian J, Xu F, et al. Breastfeeding in China: a review of changes in the past decade[J]. Int J Environ Res Public Health, 2020, 17(21): 8234.
[4]	Kouwenhoven SMP, Muts J, Finken MJJ, et al. Low-protein infant formula and obesity risk[J]. Nutrients, 2022, 14(13): 2728.
[5]	Kouwenhoven SMP, Antl N, Finken MJJ, et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: Follow-up of a randomized, double-blind, equivalence trial[J]. Clin Nutr, 2021, 40(6): 3914-3921. doi: 10.1016/j.clnu.2021.04.034 pmid: 34139464
[6]	Kouwenhoven SMP, Fleddermann M, Finken MJJ, et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula[J]. Nutrients, 2021, 13(4): 1159.
[7]	Kouwenhoven SMP, Antl N, Finken MJJ, et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial[J]. Am J Clin Nutr, 2020, 111(5): 962-974. doi: 10.1093/ajcn/nqz308 pmid: 31868201
[8]	Oropeza-Ceja LG, Rosado JL, Ronquillo D, et al. Lower protein intake supports normal growth of full-term infants fed formula: a randomized controlled trial[J]. Nutrients, 2018, 10(7): 886.
[9]	Lönnerdal B. Infant formula and infant nutrition: bioactive proteins of human milk and implications for composition of infant formulas[J]. Am J Clin Nutr, 2014, 99(3): 712S-717S.
[10]	Tinghäll Nilsson U, Lönnerdal B, Hernell O, et al. Low-protein infant formula enriched with alpha-lactalbumin during early infancy may reduce insulin resistance at 12 months: a follow-up of a randomized controlled trial[J]. Nutrients, 2024, 16(7): 1026.
[11]	周鹏, 张玉梅, 刘彪, 等. 乳类食物中β-酪蛋白的结构及营养功能[J]. 中国食物与营养, 2020, 26(4): 52-56.
	Zhou P, Zhang YM, Liu B, et al. β-casein of milk: structure and nutritional function[J]. Zhongguo Shiwu Yu Yingyang, 2020, 26(4): 52-56.
[12]	Dallas DC, Guerrero A, Khaldi N, et al. A peptidomic analysis of human milk digestion in the infant stomach reveals protein-specific degradation patterns[J]. J Nutr, 2014, 144(6): 815-820. doi: 10.3945/jn.113.185793 pmid: 24699806
[13]	Auestad N, Layman DK. Dairy bioactive proteins and peptides: a narrative review[J]. Nutr Rev, 2021, 79(Suppl 2): 36-47.
[14]	徐秀, 郭志平, 罗先琼, 等. 富含α-乳清蛋白及AA/DHA配方奶粉对足月婴儿体格生长及耐受性的影响[J]. 中国儿童保健杂志, 2006, 14(3): 223-225.
	Xu X, Guo ZP, Luo XQ, et al. Growth and tolerance of feeding a reduced protein formula enriched in bovine alpha-lactalbumin and AA/DHA in term infants[J]. Zhongguo Ertong Baojian Zazhi, 2006, 14(3): 223-225.
[15]	Li W, Liu B, Lin Y, et al. The application of lactoferrin in infant formula: the past, present and future[J]. Crit Rev Food Sci Nutr, 2024, 64(17): 5748-5767.
[16]	Schirmbeck GH, Sizonenko S, Sanches EF. Neuroprotective role of lactoferrin during early brain development and injury through lifespan[J]. Nutrients, 2022, 14(14): 2923.
[17]	Bruun S, Jacobsen LN, Ze X, et al. Osteopontin levels in human milk vary across countries and within lactation period: data from a multicenter study[J]. J Pediatr Gastroenterol Nutr, 2018, 67(2): 250-256.
[18]	Li L, Chen J, Zheng Y, et al. Gastro-intestinal digested bovine milk osteopontin modulates gut barrier biomarkers in vitro[J]. Mol Nutr Food Res, 2024, 68(4): e2200777.
[19]	Aksan A, Erdal I, Yalcin S S, et al. Osteopontin levels in human milk are related to maternal nutrition and infant health and growth[J]. Nutrients, 2021, 13(8): 2670.
[20]	West CE, Kvistgaard AS, Peerson JM, et al. Effects of osteopontin-enriched formula on lymphocyte subsets in the first 6 months of life: a randomized controlled trial[J]. Pediatr Res, 2017, 82(1): 63-71. doi: 10.1038/pr.2017.77 pmid: 28355198
[21]	Lönnerdal B, Kvistgaard AS, Peerson JM, et al. Growth, nutrition, and cytokine response of breast-fed infants and infants fed formula with added bovine osteopontin[J]. J Pediatr Gastroenterol Nutr, 2016, 62(4): 650-657.
[22]	Guo Z, Xie Q, Ren Q, et al. Enhancing immune regulation in vitro: the synergistic impact of 3'-sialyllactose and osteopontin in a nutrient blend following influenza virus infection[J]. Front Immunol, 2024, 15: 1271926.
[23]	Cai R, Zheng Y, Lane JA, et al. In vitro infant fecal fermentation metabolites of osteopontin and 2'-fucosyllactose support intestinal barrier function[J]. J Agric Food Chem, 2025, 73(2): 1642-1655.
[24]	Goulding DA, Bonnet N, Horcajada MN, et al. The impact of complexation or complex coacervation of lactoferrin and osteopontin on simulated infant gastrointestinal digestion, intestinal inflammation, and in vivo bone development[J]. Food Funct, 2024, 15(19): 9928-9940. doi: 10.1039/d4fo02790f pmid: 39259160
[25]	Jiang R, Liu L, Du X, et al. Evaluation of bioactivities of the bovine milk lactoferrin-osteopontin complex in infant formulas[J]. J Agric Food Chem, 2020, 68(22): 6104-6111.
[26]	Fontecha J, Brink L, Wu S, et al. Sources, production, and clinical treatments of milk fat globule membrane for infant nutrition and well-being[J]. Nutrients, 2020, 12(6): 1607.
[27]	Zhao J, Yi W, Liu B, et al. MFGM components promote gut Bifidobacterium growth in infant and in vitro[J]. Eur J Nutr, 2022, 61(1): 277-288.
[28]	Deoni SC, Beauchemin J, D'Sa V, et al. Enhanced brain myelination and cognitive development in young children associated with milk fat globule membrane (MFGM) intake: a temporal cohort study[J]. Brain Struct Funct, 2025, 230(4): 52.
[29]	Chen B, Jia Q, Chen Z, et al. Comparative evaluation of enriched formula milk powder with OPO and MFGM vs. breastfeeding and regular formula milk powder in full-term infants: a comprehensive study on gut microbiota, neurodevelopment, and growth[J]. Food Funct, 2024, 15(3): 1417-1430.
[30]	Meng Y, Zhou Y, Li H, et al. Effectiveness of growing-up milk containing only A2 β-casein on digestive comfort in toddlers: a randomized controlled trial in China[J]. Nutrients, 2023, 15(6): 1313.
[31]	Jianqin S, Leiming X, Lu X, et al. Effects of milk containing only A2 beta casein versus milk containing both A1 and A2 beta casein proteins on gastrointestinal physiology, symptoms of discomfort, and cognitive behavior of people with self-reported intolerance to traditional cows' milk[J]. Nutr J, 2016, 15: 35. doi: 10.1186/s12937-016-0147-z pmid: 27039383
[32]	Sheng X, Li Z, Ni J, et al. Effects of conventional milk versus milk containing only A2 β-Casein on digestion in chinese children: a randomized study[J]. J Pediatr Gastroenterol Nutr, 2019, 69(3): 375-382.
[33]	Yu W, Wang W, Sheng X. Effect of A1 protein-free formula versus conventional formula on acute respiratory infections and diarrhea in toddlers: a randomized controlled trial[J]. J Pediatr Gastroenterol Nutr, 2025, 80(4): 705-713.
[34]	Kim BJ, Kuhfeld RF, Haas JL, et al. Digestive profiles of human milk, recombinant human and bovine lactoferrin: comparing the retained intact protein and peptide release[J]. Nutrients, 2024, 16(14): 2360.

The significance, progress and challenges of optimizing the protein composition of infant formula based on human breast milk

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References 34

Related Articles 15

Metrics

Comments

Recommended 0

[1]	GAO Yajuan, DAI Nini, ZHANG Hua, LI Zailing. Diagnostic value of fecal matrix metalloproteinase 9 and its related proteins for food allergy in infants [J]. Journal of Clinical Pediatrics, 2024, 42(7): 619-625.
[2]	HOU Chi, CHEN Wenxiong, LIAO Yinting, WU Wenxiao, TIAN Yang, ZHU Haixia, PENG Bingwei, ZENG Yiru, WU Wenlin, CHEN Zongzong, LI Xiaojing. Clinical analysis of autoimmune glial fibrillary acidic protein astrocytopathy in children [J]. Journal of Clinical Pediatrics, 2023, 41(9): 656-660.
[3]	JIANG Lu, CAI Wei. Clinical applications of human milk oligosaccharides in infants [J]. Journal of Clinical Pediatrics, 2023, 41(7): 556-560.
[4]	GUO Fang, KANG Lei, DU Feifan, JIA Yanhong, XU Meixian. Myelin oligodendrocyte glycoprotein antibody-associated disease in children with prominent manifestation of optic neuritis caused by Mycoplasma pneumoniae infection: a case report [J]. Journal of Clinical Pediatrics, 2023, 41(10): 703-707.
[5]	CHEN Jinxiao, SUN Jing, YANG Wenmin, WANG Xiaoyue, WANG Xin, YANG Jian. A preliminary study on characteristics of visual evoked potentials in children with myelin oligodendrocyte glycoprotein immunoglobulin G associated disorders in the acute phase [J]. Journal of Clinical Pediatrics, 2022, 40(4): 284-289.
[6]	YAN Weihui, WU Qinging. Clinical problems in the diagnosis and treatment of food protein-induced enterocolitis syndrome [J]. Journal of Clinical Pediatrics, 2022, 40(11): 807-812.
[7]	CHEN Fan, JIAN Cui, SHU Sainan. Comparison of clinical features of food protein-induced proctocolitis and Salmonella enteritis [J]. Journal of Clinical Pediatrics, 2022, 40(11): 824-830.
[8]	LI Xinyue, WANG Shuo, ZHANG Hua, LI Zailing. Characteristics of dynamic changes in the gut microbiome of infants with cow's milk protein allergy [J]. Journal of Clinical Pediatrics, 2022, 40(11): 831-838.
[9]	KANG Yulin. The application of anti-neutrophil cytoplasmic antibodies tests in pediatric diseases [J]. Journal of Clinical Pediatrics, 2022, 40(10): 733-738.
[10]	XU Yanwen, WANG Qun, XIANG Linjuan, HUANG Lisu. SARS-CoV-2 Omicron variant infection in children: clinical manifestations and biological basis [J]. Journal of Clinical Pediatrics, 2022, 40(10): 795-800.
[11]	QIAO Xiaohong. The immunotherapy progress of PD-1/PD-L1 inhibitors in children with refractory lymphoma [J]. Journal of Clinical Pediatrics, 2022, 40(1): 1-.
[12]	TANG Xue, GUO Xia. Advances in molecular genetics, diagnosis, and treatment of malignant rhabdoid tumors in children [J]. Journal of Clinical Pediatrics, 2021, 39(9): 706-.
[13]	LIAO Xuelian, JIANG Shayi ,YANG Jingwei, et al. Feasibility of the neoadjuvant chemotherapy for children with hepatoblastoma diagnosed by serum alphafetoprotein [J]. Journal of Clinical Pediatrics, 2021, 39(8): 596-.
[14]	TU Juan, CHEN Chaoying, XIA Hua, et al. Clinical-pathological feature of poststreptococcal glomerulonephritis with the nephrotic-range proteinuria in children [J]. Journal of Clinical Pediatrics, 2021, 39(6): 429-.
[15]	ZHOU Junling, LI Weiqin, ZHANG Liya. Difference analysis of lymphocyte subsets and cerebrospinal luid protein in Guillain-Barré syndrome in children [J]. Journal of Clinical Pediatrics, 2021, 39(4): 256-.